NOVARTIS Australia has launched a new private prescription solution - Novartis Connect - to simplify access to nominated, on-label, TGA-approved, Novartis medicines.
With around 15% of medicines dispensed outside of the PBS, Novartis Connect provides universal eligibility criteria and is easily accessible.
The platform encompasses Novartis Private Prescription Program, an e-script solution that provides access to Novartis medicines via one entry point for healthcare professionals and their patients.
It is currently delivered in partnership with TerryWhite Chemmart through its app.
Novartis Connect also has a Hospital Ordering Program, a B2B ordering solution that provides hospital pharmacies with direct access to Novartis products - learn more HERE.
The above article was sent to subscribers in Pharmacy Daily's issue from 18 Aug 25
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 18 Aug 25
